CA1155395A - Pharmaceutical composition having normolipidemic and platelet anti-binding activity - Google Patents
Pharmaceutical composition having normolipidemic and platelet anti-binding activityInfo
- Publication number
- CA1155395A CA1155395A CA000357982A CA357982A CA1155395A CA 1155395 A CA1155395 A CA 1155395A CA 000357982 A CA000357982 A CA 000357982A CA 357982 A CA357982 A CA 357982A CA 1155395 A CA1155395 A CA 1155395A
- Authority
- CA
- Canada
- Prior art keywords
- normolipidemic
- pharmaceutical composition
- compound
- binding activity
- platelet anti
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 6
- 230000027455 binding Effects 0.000 title claims description 5
- 230000000444 normolipidemic effect Effects 0.000 title claims description 3
- KBFBRIPYVVGWRS-UHFFFAOYSA-N cloridarol Chemical compound C=1C2=CC=CC=C2OC=1C(O)C1=CC=C(Cl)C=C1 KBFBRIPYVVGWRS-UHFFFAOYSA-N 0.000 claims abstract description 12
- 150000001875 compounds Chemical class 0.000 claims abstract description 10
- 239000003937 drug carrier Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 2
- 238000002560 therapeutic procedure Methods 0.000 abstract description 3
- 239000011230 binding agent Substances 0.000 abstract description 2
- 229960001261 cloridarol Drugs 0.000 description 8
- 210000001772 blood platelet Anatomy 0.000 description 4
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- -1 (2-benzofuryl)-p-chlorophenyl Chemical group 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 208000006575 hypertriglyceridemia Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- FYPMFJGVHOHGLL-UHFFFAOYSA-N probucol Chemical compound C=1C(C(C)(C)C)=C(O)C(C(C)(C)C)=CC=1SC(C)(C)SC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 FYPMFJGVHOHGLL-UHFFFAOYSA-N 0.000 description 1
- NCEXYHBECQHGNR-QZQOTICOSA-N sulfasalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-QZQOTICOSA-N 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT7909513A IT1207887B (it) | 1979-08-10 | 1979-08-10 | Uso in terapia del prodotto (2benzofuril)-(p-clorofenil)-carbino lo(cloridarol dci)come normolipide mizzante e antiaggregante piastrinico |
| IT9513A/79 | 1979-08-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1155395A true CA1155395A (en) | 1983-10-18 |
Family
ID=11131363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000357982A Expired CA1155395A (en) | 1979-08-10 | 1980-08-11 | Pharmaceutical composition having normolipidemic and platelet anti-binding activity |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4296124A (enExample) |
| JP (1) | JPS5645413A (enExample) |
| BE (1) | BE884691A (enExample) |
| CA (1) | CA1155395A (enExample) |
| CH (1) | CH648756A5 (enExample) |
| DE (1) | DE3029421A1 (enExample) |
| FR (1) | FR2463135A1 (enExample) |
| GB (1) | GB2056280A (enExample) |
| IT (1) | IT1207887B (enExample) |
| LU (1) | LU82700A1 (enExample) |
| NL (1) | NL8004534A (enExample) |
| ZA (1) | ZA804822B (enExample) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1160925A (en) * | 1967-02-08 | 1969-08-06 | Menarini Sas | 2-Substituted Benzofuran Derivatives |
-
1979
- 1979-08-10 IT IT7909513A patent/IT1207887B/it active
-
1980
- 1980-08-01 GB GB8025197A patent/GB2056280A/en not_active Withdrawn
- 1980-08-02 DE DE19803029421 patent/DE3029421A1/de active Granted
- 1980-08-07 ZA ZA00804822A patent/ZA804822B/xx unknown
- 1980-08-08 LU LU82700A patent/LU82700A1/fr unknown
- 1980-08-08 BE BE0/201683A patent/BE884691A/fr not_active IP Right Cessation
- 1980-08-08 JP JP10839080A patent/JPS5645413A/ja active Granted
- 1980-08-08 CH CH6040/80A patent/CH648756A5/it not_active IP Right Cessation
- 1980-08-08 NL NL8004534A patent/NL8004534A/nl not_active Application Discontinuation
- 1980-08-11 CA CA000357982A patent/CA1155395A/en not_active Expired
- 1980-08-11 FR FR8017691A patent/FR2463135A1/fr active Granted
- 1980-08-11 US US06/176,867 patent/US4296124A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| GB2056280A (en) | 1981-03-18 |
| US4296124A (en) | 1981-10-20 |
| DE3029421A1 (de) | 1981-02-26 |
| CH648756A5 (it) | 1985-04-15 |
| NL8004534A (nl) | 1981-02-12 |
| IT1207887B (it) | 1989-06-01 |
| BE884691A (fr) | 1980-12-01 |
| DE3029421C2 (enExample) | 1990-02-22 |
| LU82700A1 (fr) | 1980-12-15 |
| FR2463135B1 (enExample) | 1983-08-12 |
| ZA804822B (en) | 1981-08-26 |
| JPH0153244B2 (enExample) | 1989-11-13 |
| FR2463135A1 (fr) | 1981-02-20 |
| IT7909513A0 (it) | 1979-08-10 |
| JPS5645413A (en) | 1981-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zimmerman et al. | A new drug for petit mal epilepsy | |
| KR20010015807A (ko) | 9-데옥시-2',9-알파-메타노-3-옥사-4,5,6-트리노르-3,7-(1',3'-인터페닐렌)-13,14-디하이드로-프로스타글란딘에프1을 이용한 말초 혈관 질환의 치료 | |
| DD279407A1 (de) | Verfahren zur herstellung eines mittels gegen aids | |
| WO2003057207A1 (en) | Methods for treating hearing loss | |
| JPS62240619A (ja) | 制癌剤 | |
| DE69626650T2 (de) | Verwendung von aminoadamantan-verbindungen als immunregulatoren | |
| JPH0296524A (ja) | 抗癌活性を有する治療薬組成物と癌の治療方法 | |
| DE69413090T2 (de) | Verwendung von 5-Amino-Phthaloylhydrazid als antihypoxisches und defensives Mittel | |
| SE462076B (sv) | Antitoemoerkomposition innehaallande diltiazem och ett antitoemoermedel som utvaeljs bland vincristin och doxorubicin, samt anvaendning av diltiazem foer framstaellning av ett antitumoermedel med potentierad verkan | |
| US2533066A (en) | Micropulverized therapeutic compositions | |
| RU2430932C1 (ru) | Сополимеры 2-метил-5-винилпиридина и n-винилпирролидона, активирующие продуцирование интерлейкина-1, и их применение в качестве противораковых агентов | |
| Bauer et al. | Metabolism of Ba140 in man | |
| Lowy et al. | Effect of radioprotective drugs on the therapeutic ratio for a mouse tumor system | |
| DE3311922A1 (de) | Antifibrotische mittel | |
| EP0028660B1 (de) | Xanthinoxydasehemmer und Verwendung von Benztriazinderivaten | |
| EP0137807A1 (en) | Antiviral composition and method for administering the same | |
| US4296124A (en) | Pharmaceutical methods | |
| Carpenter et al. | Chemotherapy of murine leprosy | |
| ATE22282T1 (de) | Pentacycloundecan derivate, verfahren zu ihrer herstellung, und diese enthaltende pharmazeutische zusammensetzungen. | |
| Kirschbaum et al. | Effect of Urethane on Maturation of Leukocytes of Mouse Myelogenous Leukemia. | |
| AT408719B (de) | Mittel zur behandlung von hepatitis c | |
| JPH05504550A (ja) | 免疫抑制剤として有用なピリミジン生合成インヒビター | |
| DE3410848A1 (de) | Arzneimittel zur behandlung von tumoren in der metastasenphase | |
| Funcke et al. | Protective action of cyclandelate in hypoxia | |
| JPS5938207B2 (ja) | 腎疾患治療剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |